In vivo assessment of natural killer cell responses during chronic feline immunodeficiency virus infection

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Simões, Rita D ^a   Howard, Kristina E ^a,b   Dean, Gregg A ^a,c  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c Veterinary Dentistry and Oral Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CD4 ANTIGEN; CD8 ANTIGEN; PERFORIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CAT DISEASE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC FELINE IMMUNODEFICIENCY VIRUS INFECTION; CONTROLLED STUDY; FEMALE; IN VIVO STUDY; INNATE IMMUNITY; LENTIVIRUS INFECTION; LISTERIA MONOCYTOGENES; LYMPH NODE; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MALE; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONHUMAN; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; CAT; CELL PROLIFERATION; FELINE IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; IMMUNOPHENOTYPING; MONONUCLEAR CELL; PATHOGENICITY; VIROLOGY;

ANIMALIA; BACTERIA (MICROORGANISMS); FELINE IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LISTERIA MONOCYTOGENES;

ANIMALS; APOPTOSIS; CATS; CELL PROLIFERATION; FEMALE; IMMUNODEFICIENCY VIRUS, FELINE; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LENTIVIRUS INFECTIONS; LEUKOCYTES, MONONUCLEAR; MALE;

EID: 84872748148     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037606     Document Type: Article

References (54)

1. Moretta A, Marcenaro E, Sivori S, Della Chiesa M, Vitale M, et al. (2005) Early liaisons between cells of the innate immune system in inflamed peripheral tissues. Trends Immunol 26 (12): 668-675.
2. Ullum H, Gotzsche PC, Victor J, Dickmeiss E, Skinhoj P, et al. (1995) Defective natural immunity: An early manifestation of human immunodeficiency virus infection. J Exp Med 182 (3): 789-799.
3. Biancotto A, Grivel JC, Iglehart SJ, Vanpouille C, Lisco A, et al. (2007) Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1. Blood 109 (10): 4272-4279.
4. Ahmad R, Sindhu ST, Tran P, Toma E, Morisset R, et al. (2001) Modulation of expression of the MHC class I-binding natural killer cell receptors, and NK activity in relation to viral load in HIV-infected/AIDS patients. J Med Virol 65 (3): 431-440.
5. Andre P, Brunet C, Guia S, Gallais H, Sampol J, et al. (1999) Differential regulation of killer cell ig-like receptors and CD94 lectin-like dimers on NK and T lymphocytes from HIV-1-infected individuals. Eur J Immunol 29(4) 1076-1085.
6. Martin MP, Gao X, Lee JH, Nelson GW, Detels R, et al. (2002) Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 31 (4): 429-434.
7. Scott-Algara D, Truong LX, Versmisse P, David A, Luong TT, et al. (2003) Cutting edge: Increased NK cell activity in HIV-1-exposed but uninfected vietnamese intravascular drug users. J Immunol 171 (11): 5663-5667.
8. Burkhard MJ, Dean GA, (2003) Transmission and immunopathogenesis of FIV in cats as a model for HIV. Curr HIV Res 1 (1): 15-29.
9. Elder JH, Lin YC, Fink E, Grant CK, (2010) Feline immunodeficiency virus (FIV) as a model for study of lentivirus infections: Parallels with HIV. Curr HIV Res 8 (1): 73-80.
10. Elder JH, Dean GA, Hoover EA, Hoxie JA, Malim MH, et al. (1998) Lessons from the cat: Feline immunodeficiency virus as a tool to develop intervention strategies against human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 14 (9): 797-801.
11. Pamer EG, (2004) Immune responses to listeria monocytogenes. Nat Rev Immunol 4 (10): 812-823.
12. Dean GA, Bernales JA, Pedersen NC, (1998) Effect of feline immunodeficiency virus on cytokine response to listeria monocytogenes in vivo. Vet Immunol Immunopathol 65 (2-4): 125-138.
13. Dean GA, LaVoy A, Yearley J, Stanton C, (2006) Cytokine modulation of the innate immune response in feline immunodeficiency virus-infected cats. J Infect Dis 193 (11): 1520-1527.
14. De Boer RJ, Mohri H, Ho DD, Perelson AS, (2003) Turnover rates of B cells, T cells, and NK cells in simian immunodeficiency virus-infected and uninfected rhesus macaques. J Immunol 170 (5): 2479-2487.
15. Kottilil S, Jackson JO, Reitano KN, O'Shea MA, Roby G, et al. (2007) Innate immunity in HIV infection: Enhanced susceptibility to CD95-mediated natural killer cell death and turnover induced by HIV viremia. J Acquir Immune Defic Syndr 46 (2): 151-159.
16. Gratzner HG, (1982) Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication. Science 218 (4571): 474-475.
17. Sachsenberg N, Perelson AS, Yerly S, Schockmel GA, Leduc D, et al. (1998) Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by ki-67 antigen. J Exp Med 187 (8): 1295-1303.
18. Martin MP, Qi Y, Gao X, Yamada E, Martin JN, et al. (2007) Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet 39 (6): 733-740.
19. Valentin A, Rosati M, Patenaude DJ, Hatzakis A, Kostrikis LG, et al. (2002) Persistent HIV-1 infection of natural killer cells in patients receiving highly active antiretroviral therapy. Proc Natl Acad Sci U S A 99 (10): 7015-7020.
20. Becknell B, Caligiuri MA, (2005) Interleukin-2, interleukin-15, and their roles in human natural killer cells. Adv Immunol 86: 209-239.
21. Bancroft GJ, Schreiber RD, Bosma GC, Bosma MJ, Unanue ER, (1987) A T cell-independent mechanism of macrophage activation by interferon-gamma. J Immunol 139 (4): 1104-1107.
22. Bancroft GJ, (1993) The role of natural killer cells in innate resistance to infection. Curr Opin Immunol 5 (4): 503-510.
23. Shegarfi H, Sydnes K, Lovik M, Inngjerdingen M, Rolstad B, et al. (2009) The role of natural killer cells in resistance to the intracellular bacterium listeria monocytogenes in rats. Scand J Immunol 70 (3): 238-244.
24. Dunn PL, North RJ, (1991) Early gamma interferon production by natural killer cells is important in defense against murine listeriosis. Infect Immun 59 (9): 2892-2900.
25. Teixeira HC, Kaufmann SH, (1994) Role of NK1.1+ cells in experimental listeriosis. NK1+ cells are early IFN-gamma producers but impair resistance to listeria monocytogenes infection. J Immunol 152 (4): 1873-1882.
26. Takada H, Matsuzaki G, Hiromatsu K, Nomoto K, (1994) Analysis of the role of natural killer cells in listeria monocytogenes infection: Relation between natural killer cells and T-cell receptor gamma delta T cells in the host defence mechanism at the early stage of infection. Immunology 82 (1): 106-112.
27. von Andrian UH, Mempel TR, (2003) Homing and cellular traffic in lymph nodes. Nat Rev Immunol 3 (11): 867-878.
28. MartIn-Fontecha A, Sebastiani S, Hopken UE, Uguccioni M, Lipp M, et al. (2003) Regulation of dendritic cell migration to the draining lymph node: Impact on T lymphocyte traffic and priming. J Exp Med 198 (4): 615-621.
29. Kang SJ, Liang HE, Reizis B, Locksley RM, (2008) Regulation of hierarchical clustering and activation of innate immune cells by dendritic cells. Immunity 29 (5): 819-833.
30. Vujanovic L, Szymkowski DE, Alber S, Watkins SC, Vujanovic NL, et al. (2010) Virally infected and matured human dendritic cells activate natural killer cells via cooperative activity of plasma membrane-bound TNF and IL-15. Blood 116 (4): 575-583.
31. Moretta A, (2002) Natural killer cells and dendritic cells: Rendezvous in abused tissues. Nat Rev Immunol 2 (12): 957-964.
32. Adam C, King S, Allgeier T, Braumuller H, Luking C, et al. (2005) DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction. Blood 106 (1): 338-344.
33. Mocikat R, Braumuller H, Gumy A, Egeter O, Ziegler H, et al. (2003) Natural killer cells activated by MHC class I(low) targets prime dendritic cells to induce protective CD8 T cell responses. Immunity 19 (4): 561-569.
34. Reeves RK, Evans TI, Gillis J, Johnson RP, (2010) Simian immunodeficiency virus infection induces expansion of alpha4beta7+ and cytotoxic CD56+ NK cells. J Virol 84 (17): 8959-8963.
35. Luteijn R, Sciaranghella G, van Lunzen J, Nolting A, Dugast AS, et al. (2011) Early viral replication in lymphnodes provides HIV with a means by which to escape NK cell mediated control. Eur J Immunol 41 (9): 2729-40.
36. Mohri H, Bonhoeffer S, Monard S, Perelson AS, Ho DD, (1998) Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. Science 279 (5354): 1223-1227.
37. Kovacs JA, Lempicki RA, Sidorov IA, Adelsberger JW, Herpin B, et al. (2001) Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV. J Exp Med 194 (12): 1731-1741.
38. Kottilil S, Chun TW, Moir S, Liu S, McLaughlin M, et al. (2003) Innate immunity in human immunodeficiency virus infection: Effect of viremia on natural killer cell function. J Infect Dis 187 (7): 1038-1045.
39. Hazenberg MD, Stuart JW, Otto SA, Borleffs JC, Boucher CA, et al. (2000) T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: A longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). Blood 95 (1): 249-255.
40. Giorgi JV, Hultin LE, McKeating JA, Johnson TD, Owens B, et al. (1999) Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 179 (4): 859-870.
41. Voskoboinik I, Dunstone MA, Baran K, Whisstock JC, Trapani JA, (2010) Perforin: Structure, function, and role in human immunopathology. Immunol Rev 235 (1): 35-54.
42. Kawasaki A, Shinkai Y, Kuwana Y, Furuya A, Iigo Y, et al. (1990) Perforin, a pore-forming protein detectable by monoclonal antibodies, is a functional marker for killer cells. Int Immunol 2 (7): 677-684.
43. Kagi D, Ledermann B, Burki K, Hengartner H, Zinkernagel RM, (1994) CD8+ T cell-mediated protection against an intracellular bacterium by perforin-dependent cytotoxicity. Eur J Immunol 24 (12): 3068-3072.
44. Alter G, Suscovich TJ, Kleyman M, Teigen N, Streeck H, et al. (2006) Low perforin and elevated SHIP-1 expression is associated with functional anergy of natural killer cells in chronic HIV-1 infection. AIDS 20 (11): 1549-1551.
45. Yang JS, English RV, Ritchey JW, Davidson MG, Wasmoen T, et al. (1996) Molecularly cloned feline immunodeficiency virus NCSU1 JSY3 induces immunodeficiency in specific-pathogen-free cats. J Virol 70 (5): 3011-3017.
46. Stevens R, Howard KE, Nordone S, Burkhard M, Dean GA, (2004) Oral immunization with recombinant listeria monocytogenes controls virus load after vaginal challenge with feline immunodeficiency virus. J Virol 78 (15): 8210-8218.
47. Dean GA, Pedersen NC, (1998) Cytokine response in multiple lymphoid tissues during the primary phase of feline immunodeficiency virus infection. J Virol 72 (12): 9436-9440.
48. Nishimura Y, Shimojima M, Sato E, Izumiya Y, Tohya Y, et al. (2004) Downmodulation of CD3epsilon expression in CD8alpha+beta- T cells of feline immunodeficiency virus-infected cats. J Gen Virol 85(Pt 9): 2585-2589.
49. Tompkins MB, Gebhard DH, Bingham HR, Hamilton MJ, Davis WC, et al. (1990) Characterization of monoclonal antibodies to feline T lymphocytes and their use in the analysis of lymphocyte tissue distribution in the cat. Vet Immunol Immunopathol 26 (4): 305-317.
50. Mikkelsen SR, Reckling SK, Egan EA, Dean GA, (2010) In vivo depletion of CD4(+)CD25(hi) regulatory T cells is associated with improved antiviral responses in cats chronically infected with feline immunodeficiency virus. Virology 403 (2): 163-172.
51. Howard KE, Fisher IL, Dean GA, Jo Burkhard M, (2005) Methodology for isolation and phenotypic characterization of feline small intestinal leukocytes. J Immunol Methods 302 (1-2): 36-53.
52. Howard KE, Reckling SK, Egan EA, Dean GA, (2010) Acute mucosal pathogenesis of feline immunodeficiency virus is independent of viral dose in vaginally infected cats. Retrovirology 7: 2.
53. Pedersen NC, Leutenegger CM, Woo J, Higgins J, (2001) Virulence differences between two field isolates of feline immunodeficiency virus (FIV-APetaluma and FIV-CPGammar) in young adult specific pathogen free cats. Vet Immunol Immunopathol 79 (1-2): 53-67.
54. Assogba BD, Leavell S, Porter K, Burkhard MJ, (2007) Mucosal administration of low-dose cell-associated feline immunodeficiency virus promotes viral latency. J Infect Dis 195 (8): 1184-1188.